Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1676
Novo Nordisk
NVO
$209B
| $8.21M | ﹤0.01% |
394,658
+143,496
| +57% | +$3.56M |
|
1677
Lumentum
LITE
$84.2B
| $8.19M | ﹤0.01% |
196,042
+49,943
| +34% | +$1.64M |
|
1678
PUT
LendingTree
TREE
$418M
| $8.17M | ﹤0.01% |
84,300
-16,300
| -16% | -$1.62M |
|
|
MLNX
1679
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $8.16M | ﹤0.01% |
188,700
+128,800
| +215% | +$5.7M |
|
1680
CALL
Prologis
PLD
$136B
| $8.15M | ﹤0.01% |
152,300
-30,600
| -17% | -$1.61M |
|
1681
iShares MSCI Taiwan ETF
EWT
$11.5B
| $8.14M | ﹤0.01% |
259,141
-27,112
| -9% | -$820K |
|
|
ADPT
1682
DELISTED
Adeptus Health Inc
ADPT
| $8.13M | ﹤0.01% |
+188,960
| New | +$8.53M |
|
1683
Alaunos Therapeutics
TCRT
$4.52M
| $8.12M | ﹤0.01% |
9,610
-600
| -6% | -$482K |
|
1684
CALL
Snap-on
SNA
$20.6B
| $8.12M | ﹤0.01% |
53,400
-21,100
| -28% | -$3.26M |
|
1685
PUT
Stratasys
SSYS
$694M
| $8.11M | ﹤0.01% |
336,800
-142,200
| -30% | -$3.1M |
|
|
MBLY
1686
DELISTED
Mobileye N.V.
MBLY
| $8.11M | ﹤0.01% |
190,606
+54,079
| +40% | +$2.5M |
|
1687
PUT
Sanofi
SNY
$109B
| $8.11M | ﹤0.01% |
212,300
+115,900
| +120% | +$4.65M |
|
1688
CALL
BorgWarner
BWA
$13.2B
| $8.11M | ﹤0.01% |
261,734
+169,264
| +183% | +$4.99M |
|
1689
CALL
Entergy
ETR
$50B
| $8.1M | ﹤0.01% |
211,200
+109,800
| +108% | +$4.37M |
|
|
HIMX
1690
Himax Technologies
HIMX
$2.41B
| $8.1M | ﹤0.01% |
943,260
+550,286
| +140% | +$5.15M |
|
|
JCP
1691
DELISTED
J.C. Penney Company, Inc.
JCP
| $8.1M | ﹤0.01% |
878,792
+684,841
| +353% | +$6.52M |
|
1692
CALL
Warner Bros
WBD
$72.1B
| $8.1M | ﹤0.01% |
300,900
+248,000
| +469% | +$6.36M |
|
1693
PUT
Autoliv
ALV
$9.05B
| $8.1M | ﹤0.01% |
105,210
+28,592
| +37% | +$2.2M |
|
|
BSCN
1694
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $8.09M | ﹤0.01% |
378,528
+287,577
| +316% | +$6.13M |
|
1695
CALL
Sinclair Inc
SBGI
$1.04B
| $8.09M | ﹤0.01% |
280,100
+106,600
| +61% | +$3.09M |
|
|
CA
1696
CALL
DELISTED
CA, Inc.
CA
| $8.09M | ﹤0.01% |
244,400
+111,800
| +84% | +$3.77M |
|
|
SIVB
1697
CALL
DELISTED
SVB Financial Group
SIVB
| $8.08M | ﹤0.01% |
73,100
+6,400
| +10% | +$666K |
|
|
NLSN
1698
PUT
DELISTED
Nielsen Holdings plc
NLSN
| $8.08M | ﹤0.01% |
150,800
+125,300
| +491% | +$6.66M |
|
1699
Hain Celestial
HAIN
$69.9M
| $8.06M | ﹤0.01% |
+226,488
| New | +$9.93M |
|
|
UN
1700
DELISTED
Unilever NV New York Registry Shares
UN
| $8.05M | ﹤0.01% |
174,580
+106,707
| +157% | +$4.92M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.